Sotera Health financials
$18.60+0.81%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.4M | $280.0M | $303.4M | $311.3M | $294.3M | $254.5M | $290.2M | $285.5M | $276.6M | $248.2M | $310.2M | $263.2M |
| Gross profit | $178.0M | $147.1M | $165.9M | $177.6M | $166.6M | $135.4M | $164.4M | $158.0M | $152.8M | $127.1M | $180.1M | $146.0M |
| Gross margin | 55.4% | 52.5% | 54.7% | 57.0% | 56.6% | 53.2% | 56.6% | 55.4% | 55.2% | 51.2% | 58.0% | 55.5% |
| Operating income | $106.8M | $75.8M | $170.3M | $111.2M | $54.4M | $26.1M | $87.1M | $80.5M | $76.8M | $53.2M | $104.0M | $76.1M |
| Net income | $53.6M | $26.6M | $34.8M | $48.4M | $8.0M | -$13.3M | $12.3M | $17.0M | $8.8M | $6.3M | $38.7M | -$13.7M |
| Net margin | 16.7% | 9.5% | 11.5% | 15.5% | 2.7% | −5.2% | 4.2% | 6.0% | 3.2% | 2.5% | 12.5% | −5.2% |
| Diluted EPS | $0.19 | $0.09 | $0.12 | $0.17 | $0.03 | $-0.05 | $0.04 | $0.06 | $0.03 | $0.02 | $0.14 | $-0.05 |
| EBITDA | $140.2M | $106.6M | $137.9M | $139.5M | $123.4M | $97.8M | $127.5M | $123.6M | $116.6M | $93.6M | $104.0M | $114.3M |
| Operating cash flow | $88.5M | $29.4M | $103.1M | $71.2M | $57.4M | $55.5M | $55.7M | $97.5M | $61.3M | $9.7M | $113.1M | $41.8M |
| Free cash flow | $42.0M | -$16.7M | $52.4M | $35.0M | $26.2M | $35.6M | -$10.2M | $61.1M | $19.4M | -$25.2M | $48.3M | -$10.2M |
| Diluted shares | 288.1M | 287.6M | 289.6M | 286.7M | 285.8M | 283.6M | 285.5M | 285.6M | 284.5M | 284.1M | 285.7M | 281.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $356.7M | $314.1M | $344.6M | $299.2M | $332.4M | $304.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.23B | $2.24B | $2.24B | $2.24B | $2.32B | $2.32B |
| Total assets | $3.31B | $3.24B | $3.26B | $3.19B | $3.22B | $3.10B |
| Total liabilities | $2.64B | $2.61B | $2.66B | $2.64B | $2.71B | $2.68B |
| Shareholders' equity | $665.6M | $622.5M | $606.0M | $550.5M | $511.3M | $414.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology